Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Normothermic Machine Perfusion Market From 2025 To 2034?
The market encompassing normothermic machine perfusion has experienced swift expansion lately, projected to reach $1.48 billion by 2025 from its $1.28 billion valuation in 2024, reflecting a compound annual growth rate of 15.7% throughout this period; this upward trajectory in the past years stems from a confluence of factors, notably the escalating need for organs, advancements leading to better preservation results, a greater reliance on organs from older donors or those considered marginal, supportive regulatory environments, increased capital flowing into medical innovations, and the imperative to shorten the duration of cold ischemia.
Anticipation surrounds the normothermic machine perfusion sector, projecting substantial expansion over the forthcoming years, where the market valuation is set to reach $2.69 billion by 2029, propelled by a steady compound annual growth rate of 16.1%; this upward trajectory is fundamentally driven by the heightened necessity to leverage suboptimal donor organs, the demonstrable improvement in transplant outcomes facilitated by NMP, the proliferation of ongoing clinical testing alongside the securing of necessary regulatory clearances, escalating capital outlay directed towards advancing organ safeguarding innovations, and a broadening acceptance within developing global markets. Key developments characterizing this projection period encompass the assimilation of artificial intelligence for sophisticated monitoring applications, the trend towards diminishing the physical size of perfusion apparatus, the alignment of these systems with remote patient care technologies, the broadening application scope to encompass organs from marginally suitable donors and those procured following circulatory death, the creation of systems capable of perfusing multiple organs simultaneously, and continuous refinement in the composition of materials used for improved biological compatibility.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24341&type=smp
Which Factors And Drivers Are Influencing The Normothermic Machine Perfusion Market In 2025?
Anticipated escalation in the need for organ replacement procedures is projected to fuel the expansion of the market centered around normothermic machine perfusion.Organ transplantation, which entails substituting a failing or diseased organ with a viable one sourced from another individual, is experiencing a surge largely attributable to the growing incidence of organ failure at its final stages, itself a consequence of long-term ailments and perfected surgical and immune-suppressing methods; this is where normothermic machine perfusion becomes vital, as it functions to keep donor organs viable and restored by circulating oxygen-rich fluid, mimicking body temperature, right up until the moment of implantation. Illustratively, data released in January 2024 by the US Department of Health & Human Services indicated that in 2023, 46,632 transplants took place utilizing organs from both living donors and those deceased, representing an 8.7 percent rise over the previous year’s figures, consequently cementing the connection between rising transplantation requirements and the upward trajectory of the normothermic machine perfusion market.
What Are The Primary Types Of Segments Analyzed In The Normothermic Machine Perfusion Market?
The normothermic machine perfusionmarket covered in this report is segmented –
1) By Product Type: Portable Normothermic Machine, Stationary Normothermic Machine
2) By Technology: Mechanical Circulation Technology, Oxygenation Technology, Monitoring Technology
3) By Application: Organ Preservation, Organ Transplantation, Research And Development
4) By End-User: Hospitals And Ambulatory Surgery Centers (ASCs), Specialty Clinics, Other End-Users
Subsegments:
1) By Portable Normothermic Machine: Handheld Portable Devices, Battery-Operated Portable Machines, Transport-Friendly Portable Units
2) By Stationary Normothermic Machine: In-Hospital Stationary Machines, Modular Stationary Systems, Advanced Fixed-Location Units
What Key Innovation Trends Are Fueling Advancements In The Normothermic Machine Perfusion Market?
Key players within the normothermic machine perfusion sector are concentrating their efforts on establishing cutting-edge research centers aimed at fast-tracking advancements, refining methods for keeping organs viable, and elevating the success rates associated with transplants. Expanding these normothermic machine perfusion operational bases bolsters the capability to both preserve organs and conduct necessary studies and clinical trials, thereby increasing both the number of successful transplants and the availability of viable organs. As an illustration, back in May 2024, OrganOx Ltd., a medical device manufacturer situated in the United Kingdom, inaugurated a fresh, expansive 18,000 square foot complex for worldwide research, development, and manufacturing in Oxford; this move was designed to boost inventive progress and collaborations, building upon the positive impact their metra device has already had globally on liver transplant results. This newly established site reflects a confident outlook on pushing forward the boundaries of scientific discovery and clinical practice through technological application to provide superior care for patients suffering from organ failure.
Who Are The Major Companies Operating In The Normothermic Machine Perfusion Market?
Major companies operating in the normothermic machine perfusion market are CVS Health Corporation, Medtronic plc, Tandem Diabetes Care Inc., Fluent Medical Inc., TransMedics Inc., XENIOS AG, RVL Pharmaceuticals plc, Xvivo Perfusion AB, LifePort Inc., Lifeline Scientific Inc., Organ Recovery Systems Inc., Bridge to Life Ltd., OrganOx Limited, Paragonix Technologies Inc., SurgiCor LLC, Waters Medical Systems LLC, InnovaHealth Partners LP, Prescient Surgical Inc., Vascular Insights LLC, Lung Bioengineering Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Normothermic Machine Perfusion Market?
North America was the largest region in the normothermic machine perfusion market in 2024. The regions covered in the normothermic machine perfusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Normothermic Machine Perfusion Market Report:
https://www.thebusinessresearchcompany.com/customise?id=24341&type=smp
Browse Through More Reports Similar to the Global Normothermic Machine Perfusion Market 2025, By The Business Research Company
Automated Dispensing Machines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/automated-dispensing-machines-global-market-report
Automated Machine Learning Automl Global Market Report 2025
Automated Machine Learning Solution Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model